Medicinal products with the active substance Octreotide (ATC: H01CB02 - prolonged-release formulations)
Arzneimittel mit dem Wirkstoff Octreotid (ATC: H01CB02 - retardierte Darreichungsformen)
Germany
Contract
BuyerAOK Sachsen - Anhalt
TypeSupplies
Estimated valuevalue not published
Published20 March 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PIK AG | 5 | 2025 |
| Novartis Pharma GmbH · Nürnberg | 5 | 2013–2026 |
| GlaxoSmithKline GmbH & Co. KG · München | 5 | 2012–2026 |
| Städtische Werke Magdeburg GmbH & Co. KG | 4 | 2025 |
| Pfizer Pharma GmbH · Berlin | 3 | 2023–2025 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201971
202060
2021100
202287
2023169
2024277
2025392
2026161
Who knows the rhythm prepares instead of reacting.
192
days until the deadline — Saturday 27 February at 22:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →